Back to Journals » Drug, Healthcare and Patient Safety » Volume 10

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]

Total article views   Abstract views HTML views PDF downloads Totals
1,803 Dovepress* 1,451 199+ 596 1,650
PubMed Central* 0 153 73 153
Totals 1,451 352 669 1,803
*Since 16 July 2018
+Since July 2016

View citations on PubMed Central and Google Scholar